Famotidine recalls

The FDA has published 15 recalls involving Famotidine since 2012. The latest was reported on 9 Sep 2026. Most were for potency & assay. Baxter Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls15since 2012
Last 12 months2reported
Class I17% of total
Ongoing2latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 7%Class II 9 60%Class III 5 33%

By year

Ongoing famotidine recalls

2 active

All famotidine recalls, newest first

15 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFamotidine Injection in Sodium Chloride Injection, 20 mg recalledFamotidineBaxter HealthcareManufacturing (CGMP) DeviationsNationwide
DrugCLASS IFamotidine Injection, USP, 20 mg per (10 mg per mL) vials recalledFamotidineFresenius Kabi USASterilityNationwide
DrugCLASS IIFamotidine Tablets, USP, 20mg bottle within recalledFamotidineGlenmark TherapeuticsOtherNationwide
DrugCLASS IIFamotidine Tablets USP 40mg recalled by Aurobindo Pharma USAFamotidineAurobindo Pharma USAOther4 states
DrugCLASS IIIFamotidine Injection, USP, 20 mg/ vial recalled by HF Acquisition CoFamotidineHF AcquisitionTemperature AbuseCT
DrugCLASS IIIFamotidine tablets, 10 mg recalled by Dr. Reddy's LaboratoriesFamotidineDr. Reddy's LaboratoriesPotency & AssayNationwide
DrugCLASS IIIFamotidine for Oral Suspension USP, 40 mg recalledFamotidineLupin PharmaceuticalsManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIFamotidine Tablets USP, 20 mg recalled by Teva Pharmaceuticals UFamotidineTeva Pharmaceuticals USAPotency & AssayNationwide
DrugCLASS IIFamotidine USP 20 mg, Rx, PKG recalled by PD-Rx PharmaceuticalsPD-Rx PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIFamotidine tablets, USP 20mg recalled by American Health PackagingAmerican Health PackagingManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIFamotidine Tablets, USP, Over the Counter recalled by Allegiant HealthAllegiant HealthManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIFamotidine Injection 20 mg recalled by Baxter HealthcareFamotidineBaxter HealthcareParticulate MatterNationwide
DrugCLASS IIIFamotidine for Oral Suspension, USP 40 mg recalled by Novel LaboratoriesFamotidineNovel LaboratoriesPotency & AssayNationwide
DrugCLASS IIFamotidine Tablet, 20 mg, Over The Counter recalled by Aidapak ServicesAidapak ServicesLabeling Errors4 states
DrugCLASS IIIFamotidine Tablets USP, 20 mg recalled by Mylan PharmaceuticalsMylan PharmaceuticalsPotency & AssayNationwide

Should you stop taking Famotidine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.